4//SEC Filing
Ammer Richard 4
Accession 0001104659-21-022190
CIK 0001824293other
Filed
Feb 11, 7:00 PM ET
Accepted
Feb 12, 6:02 PM ET
Size
5.7 KB
Accession
0001104659-21-022190
Insider Transaction Report
Form 4
Ammer Richard
Director
Transactions
- Other
Common Stock
2021-02-12$6.40/sh+47,063$301,203→ 47,063 total(indirect: By SALMON Pharma GmbH)
Footnotes (2)
- [F1]Issued immediately prior to the closing of the initial public offering of the issuer's common stock in connection with the conversion of the promissory notes held by the reporting person, as disclosed in the prospectus, dated February 9, 2021, filed with the U.S. Securities and Exchange Commission on February 11, 2021, which forms a part of the Registration Statements on Form S-1 (File Nos. 333-249636 and 333-252925), originally filed on October 23, 2020, as amended.
- [F2]The reporting person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
Documents
Issuer
Vallon Pharmaceuticals, Inc.
CIK 0001824293
Entity typeother
Related Parties
1- filerCIK 0001843671
Filing Metadata
- Form type
- 4
- Filed
- Feb 11, 7:00 PM ET
- Accepted
- Feb 12, 6:02 PM ET
- Size
- 5.7 KB